Fidelity Select Biotechnology Portfolio Overview

Fidelity Select Biotechnology Portfolio Total Revenue

Revenue analysis for FBIOX.

Quarterly Revenue

$2.49M

↑ 2.77% YoY

As of Sep 2023

Annual Revenue (TTM)

$9.88M

↑ 6.63% YoY

Trailing 12 months ending Sep 2023

Average Revenue (Comparison Companies)

Total Revenue History

Total Revenue Comparison

Annual Revenue Growth Rate (%)

Annual Revenue Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin